Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Prostate Cancer -

Prostate Cancer (eBook)

Science and Clinical Practice
eBook Download: PDF | EPUB
2015 | 2. Auflage
672 Seiten
Elsevier Science (Verlag)
978-0-12-800592-7 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
143,00 inkl. MwSt
(CHF 139,70)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Prostate Cancer, Science and Clinical Practice, Second Edition, continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments. Key chapters from the previous edition have been updated, and a plethora of new chapters describe new concepts of prostate cancer biology and newly developed therapeutics. Each chapter has been written by internationally recognized specialists on prostate cancer epidemiology, genetic susceptibility, cancer metastases, prostate physiology, proteomics, new therapeutics, and clinical trials. - Presents a comprehensive, translational source for all aspects of prostate cancer in one reference work - Provides a common language for cancer researchers, oncologists, and urologists to discuss prostate tumors and how prostate cancer metastases affects other major organ systems - Offers insights to research clinicians, giving them a key understanding the molecular basis of prostate cancer - Offers insights to cancer researchers into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays
Prostate Cancer, Science and Clinical Practice, Second Edition, continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments. Key chapters from the previous edition have been updated, and a plethora of new chapters describe new concepts of prostate cancer biology and newly developed therapeutics. Each chapter has been written by internationally recognized specialists on prostate cancer epidemiology, genetic susceptibility, cancer metastases, prostate physiology, proteomics, new therapeutics, and clinical trials. - Presents a comprehensive, translational source for all aspects of prostate cancer in one reference work- Provides a common language for cancer researchers, oncologists, and urologists to discuss prostate tumors and how prostate cancer metastases affects other major organ systems- Offers insights to research clinicians, giving them a key understanding the molecular basis of prostate cancer- Offers insights to cancer researchers into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

List of Contributors


Philip H. Abbosh MD, PhD,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA

Firas Abdollah MD,     Vattikuti Urology Institute & VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA

Mohan P. Achary PhD,     Department of Radiation Oncology and Radiology, Temple University School of Medicine, Philadelphia, PA, USA

Shaheen Alanee MD, MPH,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA

Peter C. Albertsen MD, MS,     Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA

Yousef Al-Shraideh MD,     Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

Gerald Andriole MD,     Division of Urological Surgery, Washington University in St. Louis, St. Louis, MO, USA

Janet E. Baack Kukreja MD,     Department of Urology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Richard K. Babayan MD,     Boston University School of Medicine, Boston, MA, USA

Brock R. Baker BS,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA

Christopher E. Bayne MD,     Department of Urology, The George Washington University, Washington, DC, USA

Marijo Bilusic MD, PhD,     Department of Medical Oncology, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA

Leonard P. Bokhorst MD,     Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands

David B. Cahn DO, MBS,     Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA

Daniel J. Canter MD,     Department of Urology, Fox Chase Cancer Center and Einstein Healthcare Network, Philadelphia, PA, USA

David Y.T. Chen MD, FACS,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA

Ronald C. Chen MD, MPH,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA

Juan Chipollini MD,     Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA

Peter L. Choyke MD,     Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Matthew R. Cooperberg MD, MPH,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA

Anthony Costello MD, FRACS, FRCSI,     Departments of Urology and Surgery, Royal Melbourne Hospital and University of Melbourne, Melbourne; Epworth Prostate Centre, Epworth Healthcare, Melbourne, Australia

E. David Crawford MD,     University of Colorado Health Science Center, Aurora, CO, USA

Curtiland Deville MD,     Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Sibley Memorial Hospital, Washington, DC, USA

Essel Dulaimi MD,     Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA

Danuta Dynda MD,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA

John B. Eifler MD,     Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

Cesar E. Ercole MD,     Center for Urologic Oncology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA

Daniel D. Eun MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA

Wouter Everaerts MD, PhD,     Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne; Department of Urology, Royal Melbourne Hospital, Parkville; and Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia

Izak Faiena MD,     Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

Michael A. Ferragamo MD, FACS,     Department of Urology, State University of New York, University Hospital, Stony Brook, NY, USA

Chandra K. Flack MD,     Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

Tullika Garg MD, MPH,     Urology Department, Geisinger Health System, Danville, PA, USA

Awet Gherezghihir MD,     Department of Surgery (Urology), The Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

Ciril J. Godec MD, PhD,     Department of Urology, SUNY Downstate University School of Medicine, Brooklyn, NY; Long Island College Hospital, Long Island, NY, USA

Leonard G. Gomella MD,     Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

Richard E. Greenberg MD, FACS,     Division of Urologic Oncology, Fox Chase Cancer Center, and Temple University School of Medicine, Philadelphia, PA, USA

Baruch Mayer Grob MD,     Urology Section, Hunter Holmes McGuire VA Medical Center, and Division of Urology, Virginia Commonwealth University Health System, Richmond, VA, USA

Giorgio Guazzoni MD,     Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy

Thomas J. Guzzo MD, MPH,     Division of Urology, The Hospital of the University of Pennsylvania, Philadelphia, PA, USA

Ahmed Haddad MBChB, PhD,     Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Maahum Haider MD,     Department of Urology, University of Washington School of Medicine, Seattle, WA, USA

Andrew C. Harbin MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA

Eric M. Horwitz MD,     Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Ahmed A. Hussein MD,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Urology, Cairo University, Oula, Giza, Egypt

Timothy Ito MD,     Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Thomas W. Jarrett MD,     Department of Urology, The George Washington University, Washington, DC, USA

Lawrence C. Jenkins MD, MBA,     Sexual and Reproductive Medicine Program, Urology Service, Memorial...

PDFPDF (Adobe DRM)
Größe: 56,8 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 43,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Introduction to Extant Primates

von Friderun Ankel-Simons

eBook Download (2024)
Elsevier Science (Verlag)
CHF 169,95